http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03128360-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
filingDate 1990-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8124d958633b00da8b68dfe56f63f7bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c59bdd9e969e53bcf55b568937b4eaee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_693c4b51dfbcd3baa54d5e136a7407fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929c3a6eb47900717539f616854a9bf1
publicationDate 1991-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03128360-A
titleOfInvention Imidazole compound and its use as transglutaminase inhibitor
abstract NEW MATERIAL: A compound of formula I (R 1 is lower alkyl, etc.; R 2 is H, lower alkyl, etc.; R 3 is substd. phenyl, etc.) or its acid addition salt, and an imidazolium salt of formula II (R 4 is lower alkyl or aralkyl; W is formula III, etc.; X is an anion), and a compound of formula IV (W' is formula V; Z is an anion). n EXAMPLE: 1,3-Dimethyl-2-{[3-([1-methyl-1H-imidazol-2-yl]thio)-2-oxopropyl]thio}-1 H-imidazolium. n USE: Useful as transglutaminase inhibitors for thrombolytic therapy. n PROCESS: One mole of a compound of formula VI is reacted with 1,3- dichloroacetone in the presence of a tertiary amine, then with an alkali metal salt of a mercaptoheteroaryl compound to give the compound of formula I. n COPYRIGHT: (C)1991,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015529645-A
priorityDate 1989-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5545693-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19831248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235232880

Total number of triples: 35.